Laboratorios Farmaceuticos ROVI Financial Flexibility Index
Laboratorios Farmaceuticos ROVI financial flexibility index. Laboratorios Farmaceuticos ROVI (ROVI) has a Financial Flexibility Index of 0.31x as of September 2025. Free cash flow of €91.00 Million (operating CF €73.37 Million minus capex €17.62 Million) represents 0% of total liabilities (€289.27 Million). See Laboratorios Farmaceuticos ROVI free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Laboratorios Farmaceuticos ROVI (2006–2024)
Financial flexibility index of Laboratorios Farmaceuticos ROVI from 2006 to 2024. Historical Financial Flexibility Index trend for Laboratorios Farmaceuticos ROVI across 19 annual periods. Check Laboratorios Farmaceuticos ROVI cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Laboratorios Farmaceuticos ROVI Financial Flexibility Index by Year (2006–2024)
Laboratorios Farmaceuticos ROVI financial flexibility index by year from 2006 to 2024. Year-by-year free cash flow to debt coverage for Laboratorios Farmaceuticos ROVI. For the full cash flow conversion analysis, see ROVI cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.80x | €200.50 Million | €138.28 Million | €250.48 Million | ▲ +21.8% |
| 2023 | 0.66x | €168.43 Million | €113.25 Million | €256.39 Million | ▼ -18.8% |
| 2022 | 0.81x | €288.99 Million | €237.60 Million | €357.32 Million | ▲ +11.2% |
| 2021 | 0.73x | €190.38 Million | €149.44 Million | €261.70 Million | ▲ +68.7% |
| 2020 | 0.43x | €86.57 Million | €46.88 Million | €200.74 Million | ▲ +158.7% |
| 2019 | 0.17x | €31.48 Million | €-9.04 Million | €188.82 Million | ▼ -45.1% |
| 2018 | 0.30x | €34.99 Million | €8.53 Million | €115.23 Million | ▼ -14.7% |
| 2017 | 0.36x | €37.98 Million | €18.04 Million | €106.69 Million | ▼ -41.5% |
| 2016 | 0.61x | €63.60 Million | €45.53 Million | €104.44 Million | ▲ +22.4% |
| 2015 | 0.50x | €49.29 Million | €29.39 Million | €99.06 Million | ▲ +6.5% |
| 2014 | 0.47x | €48.06 Million | €23.00 Million | €102.85 Million | ▼ -21.6% |
| 2013 | 0.60x | €54.50 Million | €29.82 Million | €91.46 Million | ▲ +71.5% |
| 2012 | 0.35x | €33.33 Million | €19.61 Million | €95.92 Million | ▲ +88.5% |
| 2011 | 0.18x | €21.04 Million | €12.68 Million | €114.09 Million | ▼ -25.1% |
| 2010 | 0.25x | €26.77 Million | €21.19 Million | €108.75 Million | ▲ +84.3% |
| 2009 | 0.13x | €12.61 Million | €9.62 Million | €94.42 Million | ▼ -57.0% |
| 2008 | 0.31x | €22.40 Million | €12.66 Million | €72.11 Million | ▲ +45.2% |
| 2007 | 0.21x | €12.88 Million | €1.15 Million | €60.23 Million | ▼ -8.7% |
| 2006 | 0.23x | €11.76 Million | €7.72 Million | €50.23 Million | — |